rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts

References

• Zhang Y, Tian J, Yuan K, et al. Distinct resting-state brain activities in heroin-dependent individuals. Brain Res 2011;1402:46–53
   PubMed Web of Science ®Google Scholar
• Xie C, Li SJ, Shao Y, Fu L, Goveas J, Ye E, et al. Identification of hyperactive intrinsic amygdala network connectivity associated with impulsivity in abstinent heroin addicts. Behav Brain Res 2011;216:639–46
   PubMed Web of Science ®Google Scholar
• Wang X, Zhou X, Liao Y, et al. Brain function of heroin addicts after withdrawal. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011;36:733–8
   PubMedGoogle Scholar
• Zijlstra F, Booij J, van den Brink W, et al. Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. Eur Neuropsychopharmacol 2008;18:262–70
   PubMed Web of Science ®Google Scholar
• Suto N, Ecke LE, Wise RA. Control of within-binge cocaine-seeking by dopamine and glutamate in the core of nucleus accumbens. Psychopharmacology (Berl) 2009;205:431–9
   PubMed Web of Science ®Google Scholar
• Suto N, Wise RA. Satiating effects of cocaine are controlled by dopamine actions in the nucleus accumbens core. J Neurosci 2011;31:17917–22
   PubMed Web of Science ®Google Scholar
• Willuhn I, Burgeno LM, Groblewski PA, et al. Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. Nat Neurosci 2014;17:704–9
   PubMed Web of Science ®Google Scholar
• Stewart J. Review. Psychological and neural mechanisms of relapse. Philos Trans R Soc Lond B Biol Sci 2008;363:3147–58
   PubMed Web of Science ®Google Scholar
• Caprioli D, Calu D, Shaham Y. Loss of phasic dopamine: a new addiction marker? Nat Neurosci 2014;17:644–6
   PubMed Web of Science ®Google Scholar
• Grabowski J, Rhoades H, Stotts A, et al. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 2004;29:969–81
   PubMed Web of Science ®Google Scholar
• Dackis CA, Gold MS. Bromocriptine as treatment of cocaine abuse. Lancet 1985;1:1151–2
   PubMed Web of Science ®Google Scholar
• Volkow ND. Stimulant medications: how to minimize their reinforcing effects? Am J Psychiatry 2006;163(3):359–61
   PubMed Web of Science ®Google Scholar
• Volkow ND, Fowler JS, Wang G-J. The addicted human brain: insights from imaging studies. J Clin Invest 2003;111:1444–51
   PubMed Web of Science ®Google Scholar
• Schmidt A, Walter M, Gerber H, et al. Inferior frontal cortex modulation with an acute dose of heroin during cognitive control. Neuropsychopharmacology 2013;38:2231–9
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhu Z, Shi J, et al. Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals. Brain Cogn 2009;71:223–8
   PubMed Web of Science ®Google Scholar
• Elman I, Borsook D, Volkow ND. Pain and suicidality: insights from reward and addiction neuroscience. Prog Neurobiol 2013;109:1–27
   PubMed Web of Science ®Google Scholar
• Marhe R, Luijten M, van de Wetering BJ, et al. Individual differences in anterior cingulate activation associated with attentional bias predict cocaine use after treatment. Neuropsychopharmacology 2013;38:1085–93
   PubMed Web of Science ®Google Scholar
• Thanos PK, Ramalhete RC, Michaelides M, et al. Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions. Synapse 2008;62:637–42
   PubMed Web of Science ®Google Scholar
• Rothman RB, Blough BE, Baumann MH. Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction. Exp Clin Psychopharmacol 2008;16:458–74
   PubMed Web of Science ®Google Scholar
• Blum K, Gardner E, Oscar-Berman M, et al. “Liking” and “wanting” linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. Curr Pharm Des 2012;18:113–18
   PubMed Web of Science ®Google Scholar
• Dahlgren A, Wargelius HL, Berglund KJ, et al. Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study. Alcohol Alcohol 2011;46:509–13
   PubMed Web of Science ®Google Scholar
• Chen TJ, Blum K, Chen AL, et al. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map. J Psychoactive Drugs 2011;43:108–27
   PubMed Web of Science ®Google Scholar
• Blum K, Oscar-Berman M, Stuller E, et al. Neurogenetics and nutrigenomics of neuro-nutrient therapy for reward deficiency syndrome (RDS): clinical ramifications as a function of molecular neurobiological mechanisms. J Addict Res Ther 2012;3:139
   Google Scholar
• Blum K, Chen TJH, Morse S, et al. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D2 agonist therapy: part 2. Postgrad Med 2010;122:214–26
   PubMed Web of Science ®Google Scholar
• Norman KA, Polyn SM, Detre GJ, et al. Beyond mind-reading: multi-voxel pattern analysis of fMRI data. Trends Cogn Sci 2006;10:424–30
   PubMed Web of Science ®Google Scholar
• Allefeld C, Haynes JD. Searchlight-based multi-voxel pattern analysis of fMRI by cross-validated MANOVA. Neuroimage 2014;89:345–57
   PubMed Web of Science ®Google Scholar
• Kriegeskorte N, Goebel R, Bandettini P. Information-based functional brain mapping. Proc Natl Acad Sci USA 2006;103:3863–8
   PubMed Web of Science ®Google Scholar
• Anchordoquy HC, McGeary C, Liu L, et al. Genotyping of three candidate genes after whole-genome preamplification of DNA collected from buccal cells. Behav Genet 2003;33:73–8
   PubMed Web of Science ®Google Scholar
• Haberstick BC, Smolen A. Genotyping of three single nucleotide polymorphisms following whole genome preamplification of DNA collected from buccal cells. Behav Genet 2004;34:541–7
   PubMed Web of Science ®Google Scholar
• Haberstick BC, Lessem JM, Hopfer CJ, et al. Monoamine oxidase A (MAOA) and antisocial behaviors in the presence of childhood and adolescent maltreatment. Am J Med Genet B Neuropsychiatr Genet 2005;135B:59–64
   PubMed Web of Science ®Google Scholar
• Vandenbergh DJ, Persico AM, Hawkins AL, et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992;14:1104–6
   PubMed Web of Science ®Google Scholar
• Van Tol HH, Wu CM, Guan HC, et al. Multiple dopamine D4 receptor variants in the human population. Nature 1992;358:149–52
   PubMed Web of Science ®Google Scholar
• Lerman C, Caporaso N, Main D, et al. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychol 1998;17:56–62
   PubMed Web of Science ®Google Scholar
• Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998;103:273–9
   PubMed Web of Science ®Google Scholar
• Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621–4
   PubMed Web of Science ®Google Scholar
• Guerini FR, Beghi E, Riboldazzi G, et al. BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease. Eur J Neurol 2009;16:1240–5
   PubMed Web of Science ®Google Scholar
• Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527–31
   PubMed Web of Science ®Google Scholar
• Hu X, Oroszi G, Chun J, et al. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005;29:8–16
   PubMed Web of Science ®Google Scholar
• Don RH, Cox PT, Wainwright BJ, et al. ‘Touchdown’ PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991;19:4008
   PubMed Web of Science ®Google Scholar
• Pohjalainen T, Rinne JO, Nagren K, et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998;3:256–60
   PubMed Web of Science ®Google Scholar
• Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999;51:593–628
   PubMed Web of Science ®Google Scholar
• Akil M, Kolachana BS, Rothmond DA, et al. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 2003;23:2008–13
   PubMed Web of Science ®Google Scholar
• Stice E, Spoor S, Bohon C, et al. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008;322:449–52
   PubMed Web of Science ®Google Scholar
• Volkow ND, Wang GJ, Begleiter H, et al. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry 2006;63:999–1008
   PubMed Web of Science ®Google Scholar
• Conner BT, Hellemann GS, Ritchie TL, et al. Genetic, personality, and environmental predictors of drug use in adolescents. J Subst Abuse Treat 2010;38:178–90
   PubMed Web of Science ®Google Scholar
• Grant S, London ED, Newlin DB, et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA 1996;93:12040–1205
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu J, Li Q, et al. Altered fronto-striatal and fronto-cerebellar circuits in heroin-dependent individuals: a resting-state fMRI study. PLoS One 2013;8:e58098
   PubMed Web of Science ®Google Scholar
• Bell RP, Foxe JJ, Nierenberg J, et al. Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals. Drug Alcohol Depend 2011;114:159–68
   PubMed Web of Science ®Google Scholar
• Maksimovskiy AL, McGlinchey RE, Fortier CB, et al. White matter and cognitive changes in veterans diagnosed with alcoholism and PTSD. J Alcohol Drug Depend 2014;2:144–4
   PubMedGoogle Scholar
• Liu H, Li L, Hao Y, et al. Disrupted white matter integrity in heroin dependence: a controlled study utilizing diffusion tensor imaging. Am J Drug Alcohol Abuse 2008;34:562–75
   PubMed Web of Science ®Google Scholar
• Ng GY, George SR. Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse. Eur J Pharmacol 1994;269:365–74
   PubMed Web of Science ®Google Scholar
• Blum K, Chen AL, Chen TJ, et al. Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model 2008;5:24
   PubMed Web of Science ®Google Scholar
• Miller DK, Bowirrat A, Manka M, et al. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports. Postgrad Med 2010;122:188–213
   PubMed Web of Science ®Google Scholar
• Tomasi D, Wang GJ, Wang R, et al. Overlapping patterns of brain activation to food and cocaine cues in cocaine abusers: association to striatal D2/D3 receptors. Hum Brain Mapp 2014; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Blum K, Trachtenberg MC, Elliott CE, et al. Enkephalinase inhibition and precursor amino acid loading improves inpatient treatment of alcohol and polydrug abusers: double-blind placebo-controlled study of the nutritional adjunct SAAVE. Alcohol 1988;5:481–93
   PubMed Web of Science ®Google Scholar
• Trachtenberg MC, Blum K. Improvement of cocaine-induced neuromodulator deficits by the neuronutrient Tropamine. J Psychoactive Drugs 1988;20:315–31
   PubMed Web of Science ®Google Scholar
• Chen TJ, Blum K, Payte JT, et al. Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy. Med Hypotheses 2004;63:538–48
   PubMed Web of Science ®Google Scholar
• Blum K, Chen TJ, Meshkin B, et al. Reward deficiency syndrome in obesity: a preliminary cross-sectional trial with a Genotrim variant. Adv Ther 2006;23:1040–51
   PubMed Web of Science ®Google Scholar
• Blum K, Chen AL, Giordano J, et al. The addictive brain: all roads lead to dopamine. J Psychoactive Drugs 2012;44:134–43
   PubMed Web of Science ®Google Scholar
• Borsten J. Dopamine for Dinner: an easy-to- follow 4 week meal plan to help break the cycle of addiction. Borsten, Los Angeles, CA; 2014; self-published
   Google Scholar